TrialNeuropsychiatric disease and treatment2023

Group-Based Symptom Trajectory of Intramuscular Administration of Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Post-Hoc Analysis.

Xiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.